Correlation Between Hikma Pharmaceuticals and Vestis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hikma Pharmaceuticals and Vestis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hikma Pharmaceuticals and Vestis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hikma Pharmaceuticals PLC and Vestis, you can compare the effects of market volatilities on Hikma Pharmaceuticals and Vestis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hikma Pharmaceuticals with a short position of Vestis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hikma Pharmaceuticals and Vestis.

Diversification Opportunities for Hikma Pharmaceuticals and Vestis

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Hikma and Vestis is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Hikma Pharmaceuticals PLC and Vestis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vestis and Hikma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hikma Pharmaceuticals PLC are associated (or correlated) with Vestis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vestis has no effect on the direction of Hikma Pharmaceuticals i.e., Hikma Pharmaceuticals and Vestis go up and down completely randomly.

Pair Corralation between Hikma Pharmaceuticals and Vestis

Assuming the 90 days horizon Hikma Pharmaceuticals PLC is expected to under-perform the Vestis. But the pink sheet apears to be less risky and, when comparing its historical volatility, Hikma Pharmaceuticals PLC is 2.08 times less risky than Vestis. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Vestis is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,908  in Vestis on September 12, 2024 and sell it today you would lose (246.00) from holding Vestis or give up 12.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy77.63%
ValuesDaily Returns

Hikma Pharmaceuticals PLC  vs.  Vestis

 Performance 
       Timeline  
Hikma Pharmaceuticals PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hikma Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hikma Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Vestis 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vestis are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Vestis unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hikma Pharmaceuticals and Vestis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hikma Pharmaceuticals and Vestis

The main advantage of trading using opposite Hikma Pharmaceuticals and Vestis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hikma Pharmaceuticals position performs unexpectedly, Vestis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vestis will offset losses from the drop in Vestis' long position.
The idea behind Hikma Pharmaceuticals PLC and Vestis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Transaction History
View history of all your transactions and understand their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon